-
Signature
-
Kaushik Ghoshal, Chief Commercial Officer, SaaS business
-
Issuer symbol
-
RMD
-
Transactions as of
-
10 Mar 2025
-
Net transactions value
-
-$514,344
-
Form type
-
4
-
Filing time
-
11 Mar 2025, 16:19:35 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$24,731 |
+169 |
+1.7% |
$146.34 |
9,894 |
10 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$22,235 |
+105 |
+1.1% |
$211.76 |
9,999 |
10 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$525,214 |
+3,589 |
+36% |
$146.34 |
13,588 |
10 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$1,245,572 |
+5,882 |
+43% |
$211.76 |
19,470 |
10 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$2,332,096 |
-9,745 |
-50% |
$239.31 |
9,725 |
10 Mar 2025 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
9,628 |
10 Mar 2025 |
Kaushik Ghoshal and Jayati Ghoshal Family Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-169 |
-100% |
$0.000000 |
0 |
10 Mar 2025 |
ResMed Common Stock |
169 |
$146.34 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-105 |
-100% |
$0.000000 |
0 |
10 Mar 2025 |
ResMed Common Stock |
105 |
$211.76 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-5,882 |
-100% |
$0.000000 |
0 |
10 Mar 2025 |
ResMed Common Stock |
5,882 |
$211.76 |
Direct |
F1, F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-3,589 |
-100% |
$0.000000 |
0 |
10 Mar 2025 |
ResMed Common Stock |
3,589 |
$146.34 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: